Melvin Chin

581 total citations
34 papers, 419 citations indexed

About

Melvin Chin is a scholar working on Oncology, General Health Professions and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Melvin Chin has authored 34 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 10 papers in General Health Professions and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Melvin Chin's work include Patient-Provider Communication in Healthcare (6 papers), Cancer survivorship and care (5 papers) and Colorectal Cancer Screening and Detection (4 papers). Melvin Chin is often cited by papers focused on Patient-Provider Communication in Healthcare (6 papers), Cancer survivorship and care (5 papers) and Colorectal Cancer Screening and Detection (4 papers). Melvin Chin collaborates with scholars based in Australia, United States and United Kingdom. Melvin Chin's co-authors include David Goldstein, Mark Harris, Heike Schütze, David Weller, Michelle Harrison, Winston Liauw, Peter Grimison, David L. Morris, Gabriel Mak and Mohammad H. Pourgholami and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Melvin Chin

31 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melvin Chin Australia 11 203 83 72 67 61 34 419
Minjoung Monica Koo United Kingdom 10 329 1.6× 70 0.8× 52 0.7× 37 0.6× 45 0.7× 16 515
Kellie S. Rath United States 13 169 0.8× 131 1.6× 75 1.0× 41 0.6× 121 2.0× 27 548
Alexis Zebrowski United States 9 159 0.8× 54 0.7× 86 1.2× 56 0.8× 19 0.3× 41 363
J. Leonard Lichtenfeld United States 15 282 1.4× 114 1.4× 114 1.6× 41 0.6× 62 1.0× 24 679
Shanthi Sivendran United States 11 167 0.8× 94 1.1× 81 1.1× 29 0.4× 20 0.3× 28 410
Kate A. McBride Australia 11 170 0.8× 104 1.3× 33 0.5× 32 0.5× 59 1.0× 39 453
Iraj Asvadi Kermani Iran 13 253 1.2× 103 1.2× 113 1.6× 123 1.8× 39 0.6× 57 647
Kalina Duncan United States 10 262 1.3× 55 0.7× 128 1.8× 43 0.6× 35 0.6× 22 637
R. Ramazani Iran 3 324 1.6× 95 1.1× 56 0.8× 50 0.7× 37 0.6× 4 575
Áurea Lima Portugal 15 99 0.5× 85 1.0× 195 2.7× 42 0.6× 40 0.7× 23 569

Countries citing papers authored by Melvin Chin

Since Specialization
Citations

This map shows the geographic impact of Melvin Chin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melvin Chin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melvin Chin more than expected).

Fields of papers citing papers by Melvin Chin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melvin Chin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melvin Chin. The network helps show where Melvin Chin may publish in the future.

Co-authorship network of co-authors of Melvin Chin

This figure shows the co-authorship network connecting the top 25 collaborators of Melvin Chin. A scholar is included among the top collaborators of Melvin Chin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melvin Chin. Melvin Chin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chauhan, Ashfaq, Melvin Chin, Meron Pitcher, et al.. (2025). Patient Safety Events Among People from Ethnic Minority Backgrounds: A Retrospective Medical Record Review of Australian Cancer Services. Journal of Racial and Ethnic Health Disparities. 13(2). 1094–1105. 1 indexed citations
2.
Taggart, Mark A., Melvin Chin, Winston Liauw, & Mark Harris. (2024). Sharing Colorectal Cancer Follow-Up Using an E-Care Plan Between Cancer Services and Primary Health Care. Studies in health technology and informatics. 310. 1517–1518.
3.
Uebel, Kerry, Maria Agaliotis, Briana K. Clifford, et al.. (2024). Promoting physical activity among cancer survivors through general practice: a realist review. Family Practice. 42(2).
5.
Parakh, Sagun, Steven Kao, Craig Lewis, et al.. (2021). Standard-Dose Osimertinib in EGFR-Mutated Non–Small-Cell Lung Adenocarcinoma With Leptomeningeal Disease. JCO Precision Oncology. 5(5). 561–568. 4 indexed citations
6.
Taggart, Jane, et al.. (2021). Challenges and solutions to sharing a cancer follow-up e-care plan between a cancer service and general practice. Public Health Research & Practice. 31(2). 9 indexed citations
7.
Harrison, Reema, Merrilyn Walton, Elizabeth Manias, et al.. (2021). Codesigning consumer engagement strategies with ethnic minority consumers in Australian cancer services: the CanEngage Project protocol. BMJ Open. 11(8). e048389–e048389. 10 indexed citations
9.
Uebel, Kerry, Maria Agaliotis, Jane Taggart, et al.. (2020). Assessing suitability for long-term colorectal cancer shared care: a scenario-based qualitative study. BMC Family Practice. 21(1). 240–240. 4 indexed citations
10.
Nowak, Anna K., Fred K. Chen, Sanjeevan Muruganandan, et al.. (2019). MA23.01 Phase II Trial of an Oral FGFR Inhibitor AZD4547 as Second or Third Line Therapy in Malignant Pleural Mesothelioma: Final Results of FRAME Study. Journal of Thoracic Oncology. 14(10). S342–S342. 1 indexed citations
11.
Long, Janet C., Deborah Debono, Rachel Williams, et al.. (2018). Using behaviour change and implementation science to address low referral rates in oncology. BMC Health Services Research. 18(1). 904–904. 28 indexed citations
12.
Lamprell, Klay, Melvin Chin, & Jeffrey Braithwaite. (2018). The plot thickens: Archetypal narrative structure in the melanoma patient journey. Cogent Medicine. 5(1). 1484053–1484053. 4 indexed citations
13.
Sandler, Carolina X., David Goldstein, Barbara Bennett, et al.. (2017). Randomized Evaluation of Cognitive-Behavioral Therapy and Graded Exercise Therapy for Post-Cancer Fatigue. Journal of Pain and Symptom Management. 54(1). 74–84. 49 indexed citations
14.
Pianta, Timothy J., John W. Pickering, Lena Succar, et al.. (2017). Dexamethasone Modifies Cystatin C-Based Diagnosis of Acute Kidney Injury During Cisplatin-Based Chemotherapy. Kidney & Blood Pressure Research. 42(1). 62–75. 17 indexed citations
15.
Lemech, Charlotte, Rachel Williams, Stephen R. Thompson, Brian C. McCaughan, & Melvin Chin. (2016). Treatment of breast cancer 2 (BRCA2)-mutant follicular dendritic cell sarcoma with a poly ADP-ribose polymerase (PARP) inhibitor: a case report. BMC Research Notes. 9(1). 386–386. 7 indexed citations
16.
Lourenço, Richard De Abreu, et al.. (2016). Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer. Oncology and Therapy. 4(1). 103–116. 7 indexed citations
17.
Falchook, Gerald S., Georgina V. Long, Razelle Kurzrock, et al.. (2014). Dose Selection, Pharmacokinetics, and Pharmacodynamics of BRAF Inhibitor Dabrafenib (GSK2118436). Clinical Cancer Research. 20(17). 4449–4458. 51 indexed citations
18.
Mak, Gabriel, Hendrik‐Tobias Arkenau, & Melvin Chin. (2014). Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment. Melanoma Research. 24(4). 408–412. 7 indexed citations
19.
Grimison, Peter, Melvin Chin, Michelle Harrison, & David Goldstein. (2006). Primary pancreatic lymphoma – pancreatic tumours that are potentially curable without resection, a retrospective review of four cases. BMC Cancer. 6(1). 117–117. 41 indexed citations
20.
McBride, Michael G., et al.. (1998). Lipid lowering therapy in patients with HIV infection. The Lancet. 352(9142). 1782–1783. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026